West Pharmaceutical Stock Target Price and Analyst Consensus

WST Stock  USD 390.20  14.85  3.96%   
The current analyst and expert consensus on West Pharmaceutical is Strong Buy with 4 hold recommendations. The current projected West Pharmaceutical target price consensus is 400.71 with 10 analyst opinions. One of the most common ways West Pharmaceutical analysts use to provide buy-or-sell recommendation to the public are conference calls analysis and financial statements evaluations. Some experts can also talk to West Pharmaceutical vendors, executives, and/or customers. West Pharmaceutical recommendation module provides expert sentiment on the projected West Pharmaceutical target price to derive its highest and lowest estimates based on target price standard deviation of 0.0. Check out Macroaxis Advice on West Pharmaceutical to cross-verify analyst projections. Unlike analyst recommendations, Macroaxis provides advice only from the perspective of investor risk tolerance and investment horizon.
Lowest Forecast
364.65
Highest Forecast
444.79
Target Price
400.71
At this time, West Pharmaceutical's Gross Profit is comparatively stable compared to the past year. Pretax Profit Margin is likely to gain to 0.25 in 2024, whereas Gross Profit Margin is likely to drop 0.26 in 2024. At this time, West Pharmaceutical's Non Currrent Assets Other are comparatively stable compared to the past year. Cash And Short Term Investments is likely to gain to about 896.6 M in 2024, whereas Common Stock Shares Outstanding is likely to drop slightly above 74.7 M in 2024.
  
It's important to approach West Pharmaceutical's target price projections with caution. While they can be useful as part of a broader investment strategy, they are inherently speculative and subject to various kinds of risk, including market volatility and unforeseen external factors. Always consider multiple aspects and do your own research when making investment decisions.
Analysts determine stock price targets through various methods, including financial modeling, peer comparison, and company analysis. The stock price target is the analyst's best estimate of the future price of a stock and is used by investors to make investment decisions. However, it is important to note that stock price targets are not guaranteed, and the actual price of a stock can differ significantly from the target due to various factors such as market conditions, economic events, and company developments.

Steps to utilize West Pharmaceutical price targets

West Pharmaceutical's stock target price is an estimate of its future price, usually made by analysts. Using West Pharmaceutical's target price to determine if it is a suitable investment can be done through the following steps:
  • Look at West Pharmaceutical's target prices provided by various analysts and compare them. This can help you gain a more balanced view of the Stock's potential.
  • Look at the analyst's track record to determine if they have a history of accurately predicting stock prices.
  • Look at the Company's financials, including revenue, earnings, and debt, to determine if it is in good financial health.
  • Consider market conditions. For example, take into account the state of the economy, competition, and regulatory environment, to determine if West Pharmaceutical's stock is likely to perform well.
  • Diversify your portfolio and do not rely solely on stock target prices to make investment decisions. Invest in a mix of stocks, bonds, and other assets to manage risk.
Remember that stock target prices are just estimates and are subject to change. Therefore, using them as one factor in a larger investment strategy is essential rather than relying solely on them to make decisions.

Additional West Pharmaceutical Value Projection Modules

Most investment researchers agree that the mispricing and readjustment of any Stock value happens often and is sometimes even predictable, but there is no strong theory explaining why it happens. The current price of West Pharmaceutical is a key component of West Pharmaceutical valuation and have some predictive power on the future returns of a West Pharmaceutical.
Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of West Pharmaceutical's price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Hype
Prediction
LowEstimatedHigh
373.85376.37378.89
Details
Intrinsic
Valuation
LowRealHigh
344.22346.74412.89
Details
Earnings
Estimates (0)
LowProjected EPSHigh
1.201.261.34
Details
Please note, it is not enough to conduct a financial or market analysis of a single entity such as West Pharmaceutical. Your research has to be compared to or analyzed against West Pharmaceutical's peers to derive any actionable benefits. When done correctly, West Pharmaceutical's competitive analysis will give you plenty of quantitative and qualitative data to validate your investment decisions or develop an entirely new strategy toward taking a position in West Pharmaceutical.

Trending Themes

If you are a self-driven investor, you will appreciate our idea-generating investing themes. Our themes help you align your investments inspirations with your core values and are essential building blocks of your portfolios. A typical investing theme is an unweighted collection of up to 20 funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of equities with common characteristics such as industry and growth potential, volatility, or market segment.
Momentum Idea
Momentum
Invested a lot of shares
Manufacturing Idea
Manufacturing
Invested over 40 shares
When determining whether West Pharmaceutical is a good investment, qualitative aspects like company management, corporate governance, and ethical practices play a significant role. A comparison with peer companies also provides context and helps to understand if West Stock is undervalued or overvalued. This multi-faceted approach, blending both quantitative and qualitative analysis, forms a solid foundation for making an informed investment decision about West Pharmaceutical Services Stock. Highlighted below are key reports to facilitate an investment decision about West Pharmaceutical Services Stock:
Check out Macroaxis Advice on West Pharmaceutical to cross-verify analyst projections. Unlike analyst recommendations, Macroaxis provides advice only from the perspective of investor risk tolerance and investment horizon.
You can also try the Idea Analyzer module to analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas.

Complementary Tools for West Stock analysis

When running West Pharmaceutical's price analysis, check to measure West Pharmaceutical's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy West Pharmaceutical is operating at the current time. Most of West Pharmaceutical's value examination focuses on studying past and present price action to predict the probability of West Pharmaceutical's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move West Pharmaceutical's price. Additionally, you may evaluate how the addition of West Pharmaceutical to your portfolios can decrease your overall portfolio volatility.
Commodity Channel
Use Commodity Channel Index to analyze current equity momentum
FinTech Suite
Use AI to screen and filter profitable investment opportunities
Competition Analyzer
Analyze and compare many basic indicators for a group of related or unrelated entities
Portfolio Diagnostics
Use generated alerts and portfolio events aggregator to diagnose current holdings
Portfolio Comparator
Compare the composition, asset allocations and performance of any two portfolios in your account
Idea Analyzer
Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas
Idea Breakdown
Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes
Money Flow Index
Determine momentum by analyzing Money Flow Index and other technical indicators
Performance Analysis
Check effects of mean-variance optimization against your current asset allocation
Correlation Analysis
Reduce portfolio risk simply by holding instruments which are not perfectly correlated
Alpha Finder
Use alpha and beta coefficients to find investment opportunities after accounting for the risk
Stocks Directory
Find actively traded stocks across global markets
The data published in West Pharmaceutical's official financial statements usually reflect West Pharmaceutical's business processes, product offerings, services, and other fundamental events. But there are other numbers, ratios, or fundamental indicators derived from these statements that are easier to understand and visualize within the underlying realities that drive quantitative information of West Pharmaceutical. For example, before you start analyzing numbers published by West accountants, it's critical to develop an understanding of what West Pharmaceutical's liquidity, profitability, and earnings quality are in the context of the Health Care Equipment & Supplies space in which it operates.
Please note, the presentation of West Pharmaceutical's financial position, as portrayed in its financial statements, is often influenced by management's estimates, judgments, and sometimes even manipulations. In the best case, West Pharmaceutical's management is honest, while the outside auditors are strict and uncompromising. Whatever the case, the imprecision that can be found in West Pharmaceutical's accounting process means that the reasonable investor should take a skeptical approach toward the financial statement analysis of West Pharmaceutical Services. Please utilize our Beneish M Score to check the likelihood of West Pharmaceutical's management manipulating its earnings.